Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Aug 15, 2025, 3:59 PM
5.23
1.55%
After-hours: Aug 15, 2025, 04:20 PM EDT

Bolt Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-63.35M -63.12M -65.08M -66.17M -63.03M -69.2M -71.29M -76.79M -81.4M -88.1M -95.26M -96.89M -97.81M -98.59M -102.47M -89.08M -76.55M
Depreciation & Amortization
1.72M 1.78M 1.85M 1.87M 1.88M 1.88M 1.85M 1.83M 1.78M 1.67M 1.56M 1.43M 1.28M 1.19M 1.05M 928K 782K
Stock-Based Compensation
5.81M 7.41M 8.29M 9.52M 9.05M 9.22M 9.28M 9.09M 9.13M 9.58M 9.6M 9.68M 9.31M 8.5M 6.93M 5.1M 3.3M
Other Working Capital
n/a -8.44M -5.71M -7.82M -9.07M -3.25M -13.81M -12.33M -11.58M -12.12M -4.38M -2.62M 12.04M 13.92M 14.96M 13.19M -4.72M
Other Non-Cash Items
1.34M 4.3M 5.8M 6.29M 7.03M 3.94M 1.58M 1.51M 1.68M 3.45M 3.76M 3.84M 3.59M 8.56M 22.68M 20.01M 19.83M
Deferred Income Tax
n/a n/a -3.06M -4.4M -5.51M -5.51M -2.45M -1.11M n/a n/a 929K 1.75M 2.49M 2.76M 1.89M 1.1M 338K
Change in Working Capital
n/a -8.44M -5.71M -7.82M -9.07M -9.86M -12.18M -4.4M -6.74M -3.06M 3.1M -1.42M 16.33M 20.51M 17.75M 15.98M -1.93M
Operating Cash Flow
-57.9M -61.29M -61.12M -63.91M -62.88M -69.53M -73.21M -69.91M -75.59M -76.5M -76.35M -81.62M -64.82M -57.07M -52.16M -45.95M -54.23M
Capital Expenditures
-41K -41K -47K -171K -203K -206K -384K -954K -1.35M -1.95M -2.33M -2.61M -2.88M -2.34M -2.67M -2.81M -2.95M
Cash Acquisitions
n/a n/a 55.43M 42.61M 28.99M n/a -72.05M -59.23M -45.17M -16.18M 439K 439K n/a n/a n/a n/a n/a
Purchase of Investments
-66.79M -88.86M -107.76M -123.75M -145.16M -164.99M -158.19M -169.79M -147.5M -180.7M -185.03M -173.04M -191.39M -313.38M -283.69M -267.76M -218.06M
Sales Maturities Of Investments
127.64M 146.32M 168.81M 180.59M 197.62M 236.23M 230.24M 231.21M 194.86M 240.52M 249.82M 220.55M 193.44M 83.51M 34.83M 22.06M 23.5M
Other Investing Acitivies
1.11M 10.35M 10.35M 23.03M 36.64M 55.43M 72.05M 61.41M 47.36M 59.81M 64.79M 47.51M 2.05M -229.86M -248.86M -245.7M -194.56M
Investing Cash Flow
61.92M 57.58M 61.15M 56.67M 52.25M 71.04M 71.66M 60.46M 46.01M 57.86M 62.46M 44.9M -835K -232.2M -251.53M -248.51M -197.5M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.14M -2.07M 39.48M
Financial Cash Flow
108K 108K 185K 185K 253K 253K 291K 291K 396K 503K 854K 1.04M 14.2M 311.11M 309.55M 308.44M 336.58M
Net Cash Flow
4.13M -3.6M 214K -7.05M -10.37M 1.77M -1.26M -9.17M -29.18M -18.14M -13.03M -35.68M -51.46M 21.84M 5.86M 13.98M 84.85M
Free Cash Flow
-57.94M -61.33M -61.17M -64.08M -63.08M -69.73M -73.6M -70.87M -76.94M -78.46M -78.68M -84.23M -67.71M -59.4M -54.84M -48.76M -57.18M